Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne, Inc. (NASDAQ: BLLN) is still in the “fresh IPO” phase where price discovery happens in public—loudly. On December 22, 2025, the molecular diagnostics company’s shares were trading at $97.36, down about 5.1% on the session, after opening above $103 and swinging through a $96.61–$103.85 intraday range. There wasn’t a new company press release dated today that materially changed the story. Instead, BLLN’s move looks like part of the normal churn that follows a high-profile debut: early enthusiasm, analyst initiations, earnings/guidance digestion, and then a tug-of-war between “this could be huge” and “but how much is already priced in?” Below
Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors, Inc. (NASDAQ: ASO) stock traded lower on Monday, December 22, 2025, as a mix of sector headlines and company-specific fundamentals collided—again reminding investors that retail is where macro nerves go to get amplified. As of the latest available trading data, ASO was around $51.21, down about 4.64% on the day, with a market cap near $3.45 billion. The down move comes even though Academy’s most recent quarterly report showed improving profitability and a narrowed full-year outlook. So what’s driving the weakness today, what do the latest forecasts say, and how is Wall Street positioning into 2026?
Via Transportation (VIA) Stock News Today: Russell 2000 Addition, Downtowner Deal, and Short-Seller Claims Fuel Volatility (Dec. 22, 2025)

Via Transportation (VIA) Stock News Today: Russell 2000 Addition, Downtowner Deal, and Short-Seller Claims Fuel Volatility (Dec. 22, 2025)

Via Transportation, Inc. (NYSE: VIA) is back in the market spotlight on Dec. 22, 2025—less because of a single headline and more because several “stock-moving forces” are colliding at once: index inclusion, fresh M&A, and a high-profile short report debating whether Via is really a software platform or a lower-margin transit operator. As of the latest available trading data today, VIA shares were around $30.70, down about $2.60 from the prior close—roughly a 7.8% decline—after trading in a wide intraday range (high near the mid-$34s, low around $30.70). *(Quick ticker hygiene note: this article is about Via Transportation (NYSE: VIA),
Dillard’s Stock (DDS) Drops on Dec. 22, 2025: Today’s News, Special Dividend Details, and Wall Street Forecasts

Dillard’s Stock (DDS) Drops on Dec. 22, 2025: Today’s News, Special Dividend Details, and Wall Street Forecasts

December 22, 2025 — Dillard’s, Inc. (NYSE: DDS) is back in the spotlight after a sharp selloff on Monday, adding fresh volatility to what’s been a remarkably strong year for one of America’s last major publicly traded department-store chains. Shares were last indicated around $610, down roughly 8% on the day after trading as high as the upper-$660s and as low as the low-$600s. The move lands at an awkward moment for investors: Dillard’s has paired steady operating performance with aggressive shareholder returns (including a $30 special dividend), but multiple research notes and data providers continue to flag valuation risk
Kohl’s Stock (NYSE: KSS) Drops on Dec. 22, 2025: Short Interest Climbs, Analyst Targets Lag After a Volatile 2025 Rally

Kohl’s Stock (NYSE: KSS) Drops on Dec. 22, 2025: Short Interest Climbs, Analyst Targets Lag After a Volatile 2025 Rally

Kohl’s Corporation stock (NYSE: KSS) sold off sharply in Monday trading on December 22, 2025, underscoring just how jumpy this name remains after a meme-stock-flavored year. By early afternoon, KSS traded around $21.6, down roughly 7% on the session, after opening near $23.20 and touching an intraday low around $21.69. Volume was a little over 2.2 million shares at the time of the quote—active, but not the kind of panic stampede you’d see in a full-blown capitulation day. StockAnalysis+1 If you’re trying to make sense of Kohl’s stock right now, the market’s “story stack” is basically three layers deep: Here’s
Dominion Energy Stock Drops on Offshore Wind Lease Pause: What Investors Should Know About NYSE:D, CVOW, Dividends and the 2026 Outlook

Dominion Energy Stock Drops on Offshore Wind Lease Pause: What Investors Should Know About NYSE:D, CVOW, Dividends and the 2026 Outlook

Dominion Energy, Inc. (NYSE: D) stock took an uncharacteristically sharp hit on December 22, 2025, sliding roughly 5%–6% into the mid‑$50s as Washington put the brakes on the U.S. offshore wind buildout—right in the middle of construction. Reuters+1 Utilities usually trade like slow-moving planets: predictable gravity, modest drama. Today was different. The reason wasn’t earnings, a dividend cut, or a surprise rate case loss. It was policy risk colliding with a $11-ish billion megaproject that Dominion has positioned as a cornerstone of Virginia’s energy future. Below is what happened, what the key headlines and analysts are saying as of 22.12.2025,
Infosys Stock (INFY) Jumps After ADR Whiplash and McCamish Settlement Update: Latest News, Forecasts, and What’s Next (Dec. 22, 2025)

Infosys Stock (INFY) Jumps After ADR Whiplash and McCamish Settlement Update: Latest News, Forecasts, and What’s Next (Dec. 22, 2025)

Infosys Limited (NSE: INFY; BSE: INFY; NYSE: INFY) is back in the spotlight on December 22, 2025—this time for a rare mix of market microstructure drama and a legal overhang getting clearer. India-listed Infosys shares rose in Monday trading after the company addressed an unusual surge in its U.S.-traded American Depositary Receipts (ADRs) and investors digested a court update tied to its U.S. subsidiary, Infosys McCamish Systems. Reuters+2Infosys+2 The immediate trigger for Monday’s move was the aftershock of Friday’s ADR spike on the New York Stock Exchange (NYSE), where Infosys said volatility in the ADR price resulted in two volatility
Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

December 22, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is back in the spotlight as its stock price whipsaws following a sharp late-week surge and a fresh round of market commentary that mixes optimism about the company’s muscle-disease pipeline with familiar concerns about cash burn in a pre-revenue biotech. As of 18:40 UTC on Dec. 22, EWTX traded at $21.29, after swinging between $27.77 and $21.18 intraday, with volume running well above a million shares. Below is a complete, news-style breakdown of the current coverage and forecasts circulating on Dec. 22, 2025, plus the trial and business milestones investors are
Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025)

Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025)

Twist Bioscience Corporation (NASDAQ: TWST) is ending 2025 with something investors in “tools + genomics” names haven’t always been able to count on: momentum that’s tied to multiple moving pieces—new product launches, partner-driven workflow wins, and a profitability narrative that’s finally getting sharper edges. On December 22, 2025, TWST shares were trading around $34.26, up about 5.4% on the session at the time of writing (midday U.S. trading). MarketScreener That pop isn’t happening in a vacuum. Over the past few weeks, the company has stacked up incremental catalysts—from a fresh licensing deal touching NGS and hot-start PCR, to product expansion
Sunrun Stock (NASDAQ: RUN) Jumps on Dec. 22, 2025: Tax-Credit Deadline, Analyst Targets, and the NRG Partnership in Focus

Sunrun Stock (NASDAQ: RUN) Jumps on Dec. 22, 2025: Tax-Credit Deadline, Analyst Targets, and the NRG Partnership in Focus

Sunrun Inc. (NASDAQ: RUN) is back in the spotlight on December 22, 2025, with shares trading sharply higher as investors weigh a fast-approaching U.S. residential solar tax-credit cutoff, a fresh wave of bullish (and less-bearish) Wall Street commentary, and new momentum around Sunrun’s grid-services strategy. By early afternoon, RUN was trading around $19.7–$19.8, up roughly 8% on the day after a prior close near $18.26, with the session range pushing up toward roughly $20. Investing.com+2Finviz+2 That single-day move matters because it’s landing in the middle of a bigger story: Sunrun’s business model is increasingly being priced as a policy-and-financing play
Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat, Inc. (NASDAQ: VSAT) shares were trading around $36.16 on Monday, December 22, 2025, up roughly 7% from the prior close—another sharp move in what has been a highly eventful year for the satellite communications company and its investors. MarketScreener The latest momentum comes as Wall Street continues to weigh three big themes around Viasat stock: Below is a complete, up-to-date breakdown of the most relevant news, forecasts, and analyst thinking available as of Dec. 22, 2025. Viasat stock price on Dec. 22, 2025: what the market is doing right now By midday on Dec. 22, VSAT was quoted near
Planet Labs Stock (PL) Surges on Dec. 22, 2025: Record Revenue, Raised FY2026 Outlook, Analyst Targets, and What Comes Next

Planet Labs Stock (PL) Surges on Dec. 22, 2025: Record Revenue, Raised FY2026 Outlook, Analyst Targets, and What Comes Next

Planet Labs PBC (NYSE: PL) is back in the market spotlight on Monday, December 22, 2025, as the stock trades near record territory after a cascade of catalysts: a blowout fiscal Q3 revenue print, sharply higher contract backlog metrics, fresh satellite milestones for its next‑gen Pelican fleet, and a wave of analyst price‑target revisions. Investing.com+1 By midday, PL was up strongly on the session after closing the prior trading day at $19.18, with intraday trading pushing above $20—a level that underscores how dramatically investor sentiment has shifted since earlier in 2025. Investing.com PL stock today: the price action driving headlines
1 569 570 571 572 573 884

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop